UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034312
Receipt number R000039118
Scientific Title Observation of changes in comprehensive immune pathology in chemotherapy including Nivolumab for patients with refractory malignant pleural mesothelioma
Date of disclosure of the study information 2018/12/01
Last modified on 2020/12/26 12:06:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observation of changes in comprehensive immune pathology in chemotherapy including Nivolumab for patients with refractory malignant pleural mesothelioma

Acronym

Observation of changes in comprehensive immune pathology in chemotherapy including Nivolumab for patients with refractory malignant pleural mesothelioma

Scientific Title

Observation of changes in comprehensive immune pathology in chemotherapy including Nivolumab for patients with refractory malignant pleural mesothelioma

Scientific Title:Acronym

Observation of changes in comprehensive immune pathology in chemotherapy including Nivolumab for patients with refractory malignant pleural mesothelioma

Region

Japan Asia(except Japan)


Condition

Condition

Malignant pleural mesothelioma

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Prediction of the effect of Nivolumab on malignant pleural mesothelioma Search for biomarkers

Basic objectives2

Others

Basic objectives -Others

Observation of comprehensive immune pathology before and after chemotherapy including Nivolbam is performed on exacerbating malignant pleural mesothelioma with progression and recurrence with exacerbation and at the time of judgment of efficacy in continuous treatment (or when a disease state changes) By doing so, we aim to search for biomarkers for predicting the effects of opigo in malignant pleural mesothelioma.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Comprehensive station immune dynamics using peripheral blood before Bivolbam administration, 5 to 7 days after administration and after about 3 months

Key secondary outcomes

Search biomarkers after analysis


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Malignant pleural mesothelioma of unresectable progression and recurrence exacerbated after cancer chemotherapy

Interventions/Control_2

Elderly subjects with non-tumor types (including mesothelioma), non-asbestos exposure and nonimmune diseases almost agreeing with age

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Malignant pleural mesothelioma of unresectable progression and recurrence exacerbated after cancer chemotherapy

Key exclusion criteria

Initial and resectable malignant pleural mesothelioma

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yasumitsu
Middle name
Last name Nishimura

Organization

Kawasaki Medical School

Division name

Department of Hygiene

Zip code

701-0192

Address

577 Mastushima, Kurashiki, Okayama, Japan

TEL

08063084002

Email

yas@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name Yasumitsu
Middle name
Last name Nishimura

Organization

Kawasaki Medical School

Division name

Department of Hygiene

Zip code

7010192

Address

577 Mastushima, Kurashiki, Okayama, Japan

TEL

086-462-1111

Homepage URL


Email

yas@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Health labor occupational injury disease clinical research project subsidy

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kawasaki Medical School

Name of secondary funder(s)

Faculty research expenses, project research expenses


IRB Contact (For public release)

Organization

Kawasaki Medical School Ethics Committee

Address

577 Matsushima

Tel

08063084002

Email

kmsrec@med.kawasaki-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 09 Month 26 Day

Date of IRB

2018 Year 10 Month 30 Day

Anticipated trial start date

2018 Year 12 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 09 Month 28 Day

Last modified on

2020 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039118


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name